ID30006A - Proses pembuatan garam mesilat trihidrat dari 1-(4-hidroksifenil)-2-(4-hidroksi-4-fenilpiperidin-1-il)-1-propanol - Google Patents
Proses pembuatan garam mesilat trihidrat dari 1-(4-hidroksifenil)-2-(4-hidroksi-4-fenilpiperidin-1-il)-1-propanolInfo
- Publication number
- ID30006A ID30006A IDP20010342A ID20010342A ID30006A ID 30006 A ID30006 A ID 30006A ID P20010342 A IDP20010342 A ID P20010342A ID 20010342 A ID20010342 A ID 20010342A ID 30006 A ID30006 A ID 30006A
- Authority
- ID
- Indonesia
- Prior art keywords
- trihidrate
- phenilpiperidin
- hydroxyphenyl
- propanol
- hydroxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Virology (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Tropical Medicine & Parasitology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- AIDS & HIV (AREA)
- Cardiology (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20067300P | 2000-04-28 | 2000-04-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
ID30006A true ID30006A (id) | 2001-11-01 |
Family
ID=22742684
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDP20010342A ID30006A (id) | 2000-04-28 | 2001-04-26 | Proses pembuatan garam mesilat trihidrat dari 1-(4-hidroksifenil)-2-(4-hidroksi-4-fenilpiperidin-1-il)-1-propanol |
Country Status (27)
Country | Link |
---|---|
US (1) | US6645986B2 (ja) |
EP (2) | EP1477479A1 (ja) |
JP (2) | JP3615496B2 (ja) |
KR (1) | KR100442718B1 (ja) |
CN (2) | CN1210262C (ja) |
AR (1) | AR028376A1 (ja) |
AT (1) | ATE277014T1 (ja) |
AU (1) | AU781436B2 (ja) |
BR (1) | BR0101630A (ja) |
CA (1) | CA2345582C (ja) |
CZ (1) | CZ20011471A3 (ja) |
DE (1) | DE60105689T2 (ja) |
DK (1) | DK1151995T3 (ja) |
ES (1) | ES2227071T3 (ja) |
HK (1) | HK1040246B (ja) |
HU (1) | HUP0101723A3 (ja) |
ID (1) | ID30006A (ja) |
IL (1) | IL142705A0 (ja) |
IN (1) | IN191027B (ja) |
PL (1) | PL347298A1 (ja) |
PT (1) | PT1151995E (ja) |
RU (1) | RU2203888C2 (ja) |
SI (1) | SI1151995T1 (ja) |
TR (1) | TR200402696T4 (ja) |
TW (1) | TW200505858A (ja) |
YU (1) | YU27701A (ja) |
ZA (1) | ZA200103320B (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU7299301A (en) * | 2000-06-21 | 2002-01-02 | Bioarray Solutions Ltd | Multianalyte molecular analysis using application-specific random particle arrays |
US6743921B2 (en) | 2002-01-24 | 2004-06-01 | Dsm Catalytica Pharmaceuticals, Inc. | Process for the preparation of nonracemic syn-1-(4-hydroxy-phenyl)-2-(4-hydroxy-4-phenyl-piperidin-1-yl)-1-propanol compounds |
CA2545653C (en) * | 2003-11-21 | 2014-07-08 | Anp Technologies, Inc. | Asymmetrically branched polymer conjugates and microarray assays |
ATE496297T1 (de) | 2005-05-02 | 2011-02-15 | Anp Technologies Inc | Polymerkonjugat-verbesserte bioassays |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0843661T3 (da) * | 1995-08-11 | 2002-07-22 | Pfizer | (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanolmethansulfonat-trihydrat |
-
2001
- 2001-04-18 YU YU27701A patent/YU27701A/sh unknown
- 2001-04-19 IL IL14270501A patent/IL142705A0/xx not_active IP Right Cessation
- 2001-04-20 IN IN358MU2001 patent/IN191027B/en unknown
- 2001-04-23 TW TW093121004A patent/TW200505858A/zh unknown
- 2001-04-23 US US09/840,580 patent/US6645986B2/en not_active Expired - Fee Related
- 2001-04-23 JP JP2001124290A patent/JP3615496B2/ja not_active Expired - Fee Related
- 2001-04-24 ZA ZA200103320A patent/ZA200103320B/xx unknown
- 2001-04-24 TR TR2004/02696T patent/TR200402696T4/xx unknown
- 2001-04-24 AT AT01303705T patent/ATE277014T1/de not_active IP Right Cessation
- 2001-04-24 PT PT01303705T patent/PT1151995E/pt unknown
- 2001-04-24 DE DE60105689T patent/DE60105689T2/de not_active Expired - Fee Related
- 2001-04-24 EP EP04013748A patent/EP1477479A1/en not_active Withdrawn
- 2001-04-24 ES ES01303705T patent/ES2227071T3/es not_active Expired - Lifetime
- 2001-04-24 SI SI200130191T patent/SI1151995T1/xx unknown
- 2001-04-24 EP EP01303705A patent/EP1151995B1/en not_active Expired - Lifetime
- 2001-04-24 DK DK01303705T patent/DK1151995T3/da active
- 2001-04-25 CZ CZ20011471A patent/CZ20011471A3/cs unknown
- 2001-04-26 CA CA002345582A patent/CA2345582C/en not_active Expired - Fee Related
- 2001-04-26 AU AU38896/01A patent/AU781436B2/en not_active Ceased
- 2001-04-26 ID IDP20010342A patent/ID30006A/id unknown
- 2001-04-26 AR ARP010101971A patent/AR028376A1/es unknown
- 2001-04-27 RU RU2001111947/04A patent/RU2203888C2/ru not_active IP Right Cessation
- 2001-04-27 HU HU0101723A patent/HUP0101723A3/hu unknown
- 2001-04-27 CN CNB011171715A patent/CN1210262C/zh not_active Expired - Fee Related
- 2001-04-27 BR BR0101630-0A patent/BR0101630A/pt not_active IP Right Cessation
- 2001-04-27 PL PL01347298A patent/PL347298A1/xx not_active Application Discontinuation
- 2001-04-27 CN CNA2004100586743A patent/CN1590373A/zh active Pending
- 2001-04-28 KR KR10-2001-0023208A patent/KR100442718B1/ko not_active IP Right Cessation
-
2002
- 2002-03-14 HK HK02101962.0A patent/HK1040246B/zh not_active IP Right Cessation
-
2004
- 2004-03-12 JP JP2004071015A patent/JP2004196823A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL1018400A1 (nl) | Collageenbuizen voor zenuwregeneratie. | |
HK1086010A1 (en) | Ppar active compounds | |
FR2820050B3 (fr) | Toupie pour jouer | |
DE60128709D1 (de) | Triazol-verbindungen als protein-kinase-inhibitoren | |
FR2856982B1 (fr) | Capsules de bouchage ameliorees et procede pour les fabriquer | |
FR2805296B1 (fr) | Profile de structure, notamment pour cloisons | |
ITTO20030250A1 (it) | Metodo per la realizzazione di pareti di rivestimento. | |
EE200300294A (et) | Sulfoonamiid-asendatud imidasotriasinoonide valmistamismeetod | |
EE200300266A (et) | Asendatud 8-arüülkinoliinid kui fosfodiesteraas-4inhibiitorid | |
MA26407A1 (fr) | Procede de preparation de combretastatines | |
DE602004002101D1 (de) | Natrium-cyanid-verfahren | |
ID30006A (id) | Proses pembuatan garam mesilat trihidrat dari 1-(4-hidroksifenil)-2-(4-hidroksi-4-fenilpiperidin-1-il)-1-propanol | |
IT1316081B1 (it) | Trappola per muridi | |
EE200200447A (et) | Meetod tubaka täitevõime parandamiseks | |
IL182353A0 (en) | Methods using glycosaminoglycans for the treatment of kidney disease | |
AU2002364774A1 (en) | Ilk inhibitors for the treatment of renal disease | |
ATE276198T1 (de) | Verfahren zur erhöhung der inneren stabilität von natriumpercarbonat | |
EE200200448A (et) | Meetod tubaka täitevõime parandamiseks | |
ITRM20010309A0 (it) | Procedimento per la produzione di composti perfluoro-organici mediante florurazione elettrochimica. | |
FI20012242A0 (fi) | Uudet farmaseuttiset yhdisteet | |
FI20012552A (fi) | Metallikarbonaatin valmistusmenetelmä | |
AR028377A1 (es) | Procedimiento para la preparacion de la sal mesilato trihidrato de 1-(4-hidroxifenil)-2-(4-hidroxi-4-fenilpiperidin-1-il)-1-propanol e intermedios utiles para dicha preparacion | |
SI1648867T1 (sl) | Ppar aktivne spojine | |
FR2815633B1 (fr) | Procede de preparation de (meth) acrylate de (dialkylphosphono) alkyle | |
ITMI20000311A0 (it) | Processo per la preparazione di eterocicli |